ICIQ’s High Throughput Experimentation (HTE) Laboratory boosts companies’ scientific and innovation projects
Jolt, ICIQ’s spin-off, secures €6 million in funding to boost its green hydrogen technology
ICIQ Enhances Mass Spectrometry Capabilities with Cutting-Edge TimsTOF flexTM Acquisition
CRYSFORMA: Salt and Co-crystal screenings to get new patents and to optimize your drug substance
CSOL’s expertise in valorization applied to electrochemistry: innovative solutions from large-scale energy production to focused niche applications
IoChem-BD, the ICIQ Open Data platform, moves towards market
The experience from a leading pharma company in the ICIQ-Joint Units: “I was impressed by the level of our discussions on Medicinal Chemistry”
Licensing opportunities and spin-off companies to scale up ICIQ technologies to companies
CRYSFORMA: Polymorphism and crystallization, key issues in drug development according to international health security
The Characterization Technologies Department will invest almost 3M € in state-of-the-art equipment in 2023
ICIQ’s Bio-Based Polymer Platform: creating innovative materials from organic waste and CO2
The ICIQ-Energy Lab: a lab originally designed to analyse CO2 reduction products that offers much more
CRYSFORMA, your partner in solid state development
TAC12 records a TV report about Jolt Solutions, a spin-off from the ICIQ
CSOL: closing the gap between ICIQ’s discoveries and industry
ICIQ-Joint Units: the best strategy to be at the state of the art in R&D
ICIQ offers its services at the online marketplace Scientist.com
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »